FOXM1 and cancer: However, when SMYD2 is transactivated in cancer cells, stabilized β-catenin is methylated by SMYD2, binds to FOXM1, enters into the nucleus with FOXM1, and then activates downstream genes in the Wnt/β-catenin/TCF pathway.